 | • レポートコード：MRC23Q38899 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のボルチオキセチン臭化水素酸塩錠市場について調査・分析し、世界のボルチオキセチン臭化水素酸塩錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（5mg、10mg、20mg）、用途別セグメント分析（抗うつ薬、抗不安薬）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、H.Lundbeck A/S、Kanghong Pharmaceutical、Takeda Pharmaceuticals USA、Takeda Pharmaceutical、Zydus Pharms、CSPC Ouyi Pharmaceutical、Brilliant Pharmaceutical、Chiatai Tianqing、Sino Biopharmaceuticalなどが含まれています。世界のボルチオキセチン臭化水素酸塩錠市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ボルチオキセチン臭化水素酸塩錠市場規模を推定する際に考慮しました。本レポートは、ボルチオキセチン臭化水素酸塩錠の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ボルチオキセチン臭化水素酸塩錠に関するビジネス上の意思決定に役立てることを目的としています。 ・ボルチオキセチン臭化水素酸塩錠市場の概要 - 製品の定義 - ボルチオキセチン臭化水素酸塩錠のタイプ別セグメント - 世界のボルチオキセチン臭化水素酸塩錠市場規模：タイプ別分析（5mg、10mg、20mg） - ボルチオキセチン臭化水素酸塩錠の用途別セグメント - 世界のボルチオキセチン臭化水素酸塩錠市場規模：用途別分析（抗うつ薬、抗不安薬） - 世界のボルチオキセチン臭化水素酸塩錠市場規模予測（2018年-2029年） - ボルチオキセチン臭化水素酸塩錠の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ボルチオキセチン臭化水素酸塩錠市場の競争状況およびトレンド ・ボルチオキセチン臭化水素酸塩錠の地域別市場規模 - 北米のボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - アメリカのボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - ヨーロッパのボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - アジア太平洋のボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - 中国のボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - 日本のボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - 韓国のボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - インドのボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - オーストラリアのボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - 中南米のボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） - 中東・アフリカのボルチオキセチン臭化水素酸塩錠市場規模（2018年-2029年） ・タイプ別セグメント：5mg、10mg、20mg - 世界のボルチオキセチン臭化水素酸塩錠のタイプ別販売量（2018年-2023年） - 世界のボルチオキセチン臭化水素酸塩錠のタイプ別売上（2018年-2023年） - 世界のボルチオキセチン臭化水素酸塩錠のタイプ別価格 ・用途別セグメント：抗うつ薬、抗不安薬 - 世界のボルチオキセチン臭化水素酸塩錠の用途別販売量（2018年-2023年） - 世界のボルチオキセチン臭化水素酸塩錠の用途別売上（2018年-2023年） - 世界のボルチオキセチン臭化水素酸塩錠の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 H.Lundbeck A/S、Kanghong Pharmaceutical、Takeda Pharmaceuticals USA、Takeda Pharmaceutical、Zydus Pharms、CSPC Ouyi Pharmaceutical、Brilliant Pharmaceutical、Chiatai Tianqing、Sino Biopharmaceutical ・産業チェーンと販売チャネルの分析 - ボルチオキセチン臭化水素酸塩錠産業チェーン分析 - ボルチオキセチン臭化水素酸塩錠の主要原材料 - ボルチオキセチン臭化水素酸塩錠の販売チャネル - ボルチオキセチン臭化水素酸塩錠のディストリビューター - ボルチオキセチン臭化水素酸塩錠の主要顧客 ・ボルチオキセチン臭化水素酸塩錠市場ダイナミクス - ボルチオキセチン臭化水素酸塩錠の業界動向 - ボルチオキセチン臭化水素酸塩錠市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Vortioxetine Hydrobromide Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Vortioxetine Hydrobromide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Vortioxetine Hydrobromide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Vortioxetine Hydrobromide Tablets include H.Lundbeck A/S, Kanghong Pharmaceutical, Takeda Pharmaceuticals USA, Takeda Pharmaceutical, Zydus Pharms, CSPC Ouyi Pharmaceutical, Brilliant Pharmaceutical, Chiatai Tianqing and Sino Biopharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vortioxetine Hydrobromide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vortioxetine Hydrobromide Tablets.
The Vortioxetine Hydrobromide Tablets market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vortioxetine Hydrobromide Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vortioxetine Hydrobromide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
H.Lundbeck A/S
Kanghong Pharmaceutical
Takeda Pharmaceuticals USA
Takeda Pharmaceutical
Zydus Pharms
CSPC Ouyi Pharmaceutical
Brilliant Pharmaceutical
Chiatai Tianqing
Sino Biopharmaceutical
Segment by Type
5mg
10mg
20mg
Segment by Application
Antidepressants
Anxiolytics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vortioxetine Hydrobromide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vortioxetine Hydrobromide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Vortioxetine Hydrobromide Tablets Market Overview
1.1 Product Overview and Scope of Vortioxetine Hydrobromide Tablets
1.2 Vortioxetine Hydrobromide Tablets Segment by Type
1.2.1 Global Vortioxetine Hydrobromide Tablets Market Value Comparison by Type (2023-2029)
1.2.2 5mg
1.2.3 10mg
1.2.4 20mg
1.3 Vortioxetine Hydrobromide Tablets Segment by Application
1.3.1 Global Vortioxetine Hydrobromide Tablets Market Value by Application: (2023-2029)
1.3.2 Antidepressants
1.3.3 Anxiolytics
1.4 Global Vortioxetine Hydrobromide Tablets Market Size Estimates and Forecasts
1.4.1 Global Vortioxetine Hydrobromide Tablets Revenue 2018-2029
1.4.2 Global Vortioxetine Hydrobromide Tablets Sales 2018-2029
1.4.3 Global Vortioxetine Hydrobromide Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vortioxetine Hydrobromide Tablets Market Competition by Manufacturers
2.1 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Vortioxetine Hydrobromide Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Vortioxetine Hydrobromide Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Product Type & Application
2.7 Vortioxetine Hydrobromide Tablets Market Competitive Situation and Trends
2.7.1 Vortioxetine Hydrobromide Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vortioxetine Hydrobromide Tablets Players Market Share by Revenue
2.7.3 Global Vortioxetine Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vortioxetine Hydrobromide Tablets Retrospective Market Scenario by Region
3.1 Global Vortioxetine Hydrobromide Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vortioxetine Hydrobromide Tablets Global Vortioxetine Hydrobromide Tablets Sales by Region: 2018-2029
3.2.1 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2018-2023
3.2.2 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2024-2029
3.3 Global Vortioxetine Hydrobromide Tablets Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2018-2029
3.3.1 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2018-2023
3.3.2 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2024-2029
3.4 North America Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.4.1 North America Vortioxetine Hydrobromide Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
3.4.3 North America Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.5.1 Europe Vortioxetine Hydrobromide Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
3.5.3 Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Vortioxetine Hydrobromide Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.7.1 Latin America Vortioxetine Hydrobromide Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
3.7.3 Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Vortioxetine Hydrobromide Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vortioxetine Hydrobromide Tablets Sales by Type (2018-2029)
4.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Type (2018-2023)
4.1.2 Global Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029)
4.1.3 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
4.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2029)
4.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2023)
4.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029)
4.2.3 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Vortioxetine Hydrobromide Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vortioxetine Hydrobromide Tablets Sales by Application (2018-2029)
5.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Application (2018-2023)
5.1.2 Global Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029)
5.1.3 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
5.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2029)
5.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2023)
5.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029)
5.2.3 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Vortioxetine Hydrobromide Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 H.Lundbeck A/S
6.1.1 H.Lundbeck A/S Corporation Information
6.1.2 H.Lundbeck A/S Description and Business Overview
6.1.3 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product Portfolio
6.1.5 H.Lundbeck A/S Recent Developments/Updates
6.2 Kanghong Pharmaceutical
6.2.1 Kanghong Pharmaceutical Corporation Information
6.2.2 Kanghong Pharmaceutical Description and Business Overview
6.2.3 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.2.5 Kanghong Pharmaceutical Recent Developments/Updates
6.3 Takeda Pharmaceuticals USA
6.3.1 Takeda Pharmaceuticals USA Corporation Information
6.3.2 Takeda Pharmaceuticals USA Description and Business Overview
6.3.3 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product Portfolio
6.3.5 Takeda Pharmaceuticals USA Recent Developments/Updates
6.4 Takeda Pharmaceutical
6.4.1 Takeda Pharmaceutical Corporation Information
6.4.2 Takeda Pharmaceutical Description and Business Overview
6.4.3 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.4.5 Takeda Pharmaceutical Recent Developments/Updates
6.5 Zydus Pharms
6.5.1 Zydus Pharms Corporation Information
6.5.2 Zydus Pharms Description and Business Overview
6.5.3 Zydus Pharms Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zydus Pharms Vortioxetine Hydrobromide Tablets Product Portfolio
6.5.5 Zydus Pharms Recent Developments/Updates
6.6 CSPC Ouyi Pharmaceutical
6.6.1 CSPC Ouyi Pharmaceutical Corporation Information
6.6.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.6.3 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.6.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.7 Brilliant Pharmaceutical
6.6.1 Brilliant Pharmaceutical Corporation Information
6.6.2 Brilliant Pharmaceutical Description and Business Overview
6.6.3 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.7.5 Brilliant Pharmaceutical Recent Developments/Updates
6.8 Chiatai Tianqing
6.8.1 Chiatai Tianqing Corporation Information
6.8.2 Chiatai Tianqing Description and Business Overview
6.8.3 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product Portfolio
6.8.5 Chiatai Tianqing Recent Developments/Updates
6.9 Sino Biopharmaceutical
6.9.1 Sino Biopharmaceutical Corporation Information
6.9.2 Sino Biopharmaceutical Description and Business Overview
6.9.3 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.9.5 Sino Biopharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vortioxetine Hydrobromide Tablets Industry Chain Analysis
7.2 Vortioxetine Hydrobromide Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vortioxetine Hydrobromide Tablets Production Mode & Process
7.4 Vortioxetine Hydrobromide Tablets Sales and Marketing
7.4.1 Vortioxetine Hydrobromide Tablets Sales Channels
7.4.2 Vortioxetine Hydrobromide Tablets Distributors
7.5 Vortioxetine Hydrobromide Tablets Customers
8 Vortioxetine Hydrobromide Tablets Market Dynamics
8.1 Vortioxetine Hydrobromide Tablets Industry Trends
8.2 Vortioxetine Hydrobromide Tablets Market Drivers
8.3 Vortioxetine Hydrobromide Tablets Market Challenges
8.4 Vortioxetine Hydrobromide Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer